Last Updated : October 7, 2020
CADTH is pleased to announce that we have resumed activities in our Scientific Advice Program. We are once again accepting applications for meetings that will be held in February 2021 and beyond. At this point, all meetings will be held virtually until further notice. Please keep in mind that time periods may fill up quickly and we may not be able to accommodate all requests.
Earlier this year, the Scientific Advice Program was temporarily paused due to the pandemic.
The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.